Anterogen.Co.,Ltd. (KOSDAQ: A065660)
Health Care · Biotechnology · KR
₩15,140.00
-5.26% today · -39.4% 1Y
Anterogen.Co.,Ltd. (KOSDAQ: A065660) operates in the Biotechnology industry within the Health Care sector. The company is valued at $109.31M.
Over the last twelve months the share price has lost 39.4%, trading between 13.50K and 61.80K.
Tweenvest scores Anterogen.Co.,Ltd. across four factors: quality 52/100, value 60/100. Its strongest factor is value.
A065660 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $109.31M
- Revenue (TTM)
- $5.40M
- P/E
- —
- EPS
- -161.73
- Dividend yield
- —
- Beta (5Y)
- -0.12
- 52-week high
- ₩61,800.00
- 52-week low
- ₩13,500.00
- Avg volume (3M)
- —
- Shares outstanding
- 10.01M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $266.00 | +0.08% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.45 | +0.05% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.74 | -0.02% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.00 | -0.15% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $832.63 | -0.11% |
| argenx SEENXTBR: ARGX | $64.17B | €909.60 | +3.46% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $157.49 | -0.84% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.